References
- Bhargava P, Calabresi P. 2015. Novel therapies for memory cells in autoimmune diseases. Clin Exp Immunol. 180:353–360.
- Buenafe A, Tsaknaridis L, Spencer L, Hicks K, McMahan R, Watson L, Culbertson N, Latocha D, Wegmann K, Finn T, et al. 2004. Specificity of regulatory CD4+CD25+ T-cells for self-T-cell receptor determinants. J Neurosci Res. 76:129–140.
- Compston A, Coles A. 2002. Multiple sclerosis. Lancet. 359:1221–1231.
- Deibler GE, Martenson RE, Kies MW. 1972. Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species. Prep Biochem. 2:139–165.
- Fox E, Wynn D, Cohan S, Rill D, McGuire D, Markowitz C. 2012. A randomized clinical trial of autologous T-cell therapy in multiple sclerosis: Subset analysis and implications for trial design. Mult Scler.18:843–852.
- Goverman J. 2009. Autoimmune T-cell responses in the central nervous system. Nat Rev Immunol. 9:393–407.
- Gutcher I, Becher B. 2007. APC-derived cytokines and T-cell polarization in autoimmune inflammation. J Clin Invest. 117:1119–1127.
- Hellings N, Raus J, Stinissen P. 2002. Insights into the immunopathogenesis of multiple sclerosis. Immunol Res. 25:27–51.
- Huang X, Wu H, Lu Q. 2014. The mechanisms and applications of T cell vaccination for autoimmune diseases: A comprehensive review. Clin Rev Allergy Immunol. 47:219–233.
- Ivanova I, Seledtsova G, Mamaev S, Shishkov A, Seledtsov V. 2014. Immune responses induced by T-cell vaccination in patients with rheumatoid arthritis. Hum Vaccin Immunother. 10:1221–1227.
- Ivanova I, Seledtsov V, Banul N, Samarin D, Seledtsova G, Savkin I, Shirinsky V, Pronkina N, Kozlov V. 2005. Preparation of T-cell vaccine and application in treating multiple sclerosis. Med Immunol (Russia). 7:27–32.
- Ivanova I, Seledtsov V, Seledtsova G, Mamaev S, Potyemkin A, Seledtsov D, Kozlov V. 2008. Induction of anti-idiotypic immune response with autologous T-cell vaccine in patients with multiple sclerosis. Bull Exp Biol Med. 146:133–138.
- Mannie M, Curtis A. 2013. Tolerogenic vaccines for multiple sclerosis. Hum Vaccin Immunother. 9:1032–1038.
- Okuda Y, Okuda M, Apatoff B, Posnett D. 2005. The activation of memory CD4+ T-cells and CD8+ T-cells in patients with multiple sclerosis. J Neurol Sci. 235:11–17.
- Okun E, Mattson M, Arumugam T. 2010. Involvement of Fc receptors in disorders of the central nervous system. Neuromolecular Med. 12:164–178.
- Seledtsov D, Seledtsov V, Ivanova I, Litvinova L. 2010. Antigen-specific immunotherapy of multiple sclerosis. Cytokines Inflamm (Russia). 1:3–12.
- Seledtsov VI, Seledtsova GV. 2012. A balance between tissue-destructive and tissue-protective immunities: A role of toll-like receptors in regulation of adaptive immunity. Immunobiology. 217:430–435.
- Tanel A, Fonseca S, Yassine-Diab B, Bordi R, Zeidan J, Shi Y, Benne C, Sékaly R. 2009. Cellular and molecular mechanisms of memory T-cell survival. Expert Rev Vaccines. 8:299–312.
- Vandenbark A, Abulafia-Lapid R. 2008. Autologous T-cell vaccination for multiple sclerosis: A perspective on progress. BioDrugs. 22: 265–273.
- Zang Y, Hong J, Rivera V, Killian J, Zhang J. 2000. Preferential recognition of TCR hypervariable regions by human anti-idiotypic T-cell induced by T cell vaccination. J Immunol. 164:4011–4017.